Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.
- Cat.No. 产品名称 Information
- GC11837 MI-136 A menin-MLL inhibitor
- GC11418 MI-2 An inhibitor of menin-MLL fusion protein interactions
- GC10388 MI-2 (hydrochloride) An inhibitor of menin-MLL interactions
- GC12199 MI-3 An inhibitor of menin-MLL fusion protein interactions
- GC12173 MI-nc (hydrochloride) A negative control for MI-2